b-cell therapies in relapsing ms: clarifying the options in an expanding treatment landscape
Published 3 years ago • 7.4K plays • Length 26:57Download video MP4
Download video MP3
Similar videos
-
1:03:27
the rise of b-cell therapies in relapsing ms
-
31:37
highly effective disease-modifying therapies for multiple sclerosis
-
32:35
targeting btk in the treatment of patients with ms
-
29:38
leveraging the power of anti-cd20 mabs in patient-centric multiple sclerosis care
-
0:16
how b cell killers treat ms
-
32:33
personalizing multiple sclerosis care in an era of new therapeutic options
-
32:36
btk inhibition and the future of ms management
-
1:09:38
upgrading the sequential therapy tool kit for b-cell malignancies
-
38:37
ms treatment decisions before, during, and after pregnancy
-
58:40
innovations and imaging in ms: examining the evidence, looking toward the future of btk inhibitors
-
35:57
"the role of b-cells in ms& need for high efficacy treatment in ms"- lecture
-
48:33
btk inhibitors for ms: progress in the development of an emerging therapeutic approach
-
1:00:00
novel btk inhibitors: overcoming intolerance, resistance, and other challenges in b-cell cancers
-
22:36
progress with btk inhibitors: a journey through the mechanisms of covalent and noncovalent options
-
29:59
touchtalks expert perspective on improving patient outcomes in relapsing ms.
-
30:36
optimizing the management of patients with relapsing forms of ms
-
1:48
b-cells in the pathogenesis of ms
-
32:07
addressing barriers to the ready recognition and timely treatment of pediatric multiple sclerosis
-
1:12:00
b cell therapies and multiple sclerosis webinar, 09 june 2021.